日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab

贝培加地白介素联合纳武利尤单抗治疗的疗效基线生物标志物和治疗期间免疫谱变化

Gogas, Helen; Ravimohan, Shruthi; Datta, Antara; Chhibber, Aparna; Couselo, Eva Muñoz; Diab, Adi; Pereira, Caio; Quéreux, Gaëlle; Sandhu, Shahneen; Curti, Brendan; Khushalani, Nikhil I; Taylor, Matthew H; Daniels, Gregory A; Spreafico, Anna; Meniawy, Tarek; Van Den Eertwegh, Alfons J M; Sun, Yongliang; Arriaga, Yull; Zhou, Ming; Long, Georgina V; Lebbé, Céleste

Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results

贝培加地白介素联合纳武利尤单抗治疗未经治疗的晚期黑色素瘤:开放标签、III期PIVOT IO 001试验结果

Diab, Adi; Gogas, Helen; Sandhu, Shahneen; Long, Georgina V; Ascierto, Paolo A; Larkin, James; Sznol, Mario; Franke, Fabio; Ciuleanu, Tudor E; Pereira, Caio; Muñoz Couselo, Eva; Bronzon Damian, Fernanda; Schenker, Michael; Perfetti, Aldo; Lebbe, Celeste; Quéreux, Gaëlle; Meier, Friedegund; Curti, Brendan D; Rojas, Carlos; Arriaga, Yull; Yang, Haisu; Zhou, Ming; Ravimohan, Shruthi; Statkevich, Paul; Tagliaferri, Mary A; Khushalani, Nikhil I

Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory Syndrome

成人人类免疫缺陷病毒合并结核病患者开始抗逆转录病毒治疗后肺功能下降:呼吸道免疫重建炎症综合征的潜在表现

Auld, Sara C; Maenetje, Pholo; Ravimohan, Shruthi; Weissman, Drew; Ncube, Itai; Mlotshwa, Mandla; Ratsela, Nelly; Chase, William; Vangu, Mboyo-Di-Tamba; Wallis, Robert; Churchyard, Gavin; Kornfeld, Hardy; Bisson, Gregory P

Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis

成人人类免疫缺陷病毒/结核病患者接受抗逆转录病毒治疗期间的肺损伤

Ravimohan, Shruthi; Auld, Sara C; Maenetje, Pholo; Ratsela, Nelly; Mlotshwa, Mandla; Ncube, Itai; Smith, Jonathan P; Vangu, Mboyo-Di-Tamba; Sebe, Modulakgotla; Kossenkov, Andrew; Weissman, Drew; Wallis, Robert S; Churchyard, Gavin; Kornfeld, Hardy; Bisson, Gregory P

Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study

优化HIV/结核病合并感染患者乙胺丁醇的给药剂量:一项群体药代动力学建模和模拟研究

Mehta, Krina; Ravimohan, Shruthi; Pasipanodya, Jotam G; Srivastava, Shashikant; Modongo, Chawangwa; Zetola, Nicola M; Weissman, Drew; Ivaturi, Vijay; Gumbo, Tawanda; Bisson, Gregory P; Vinnard, Christopher

Tuberculosis and lung damage: from epidemiology to pathophysiology

结核病与肺损伤:从流行病学到病理生理学

Ravimohan, Shruthi; Kornfeld, Hardy; Weissman, Drew; Bisson, Gregory P

Common Variation in NLRP3 Is Associated With Early Death and Elevated Inflammasome Biomarkers Among Advanced HIV/TB Co-infected Patients in Botswana

NLRP3常见变异与博茨瓦纳晚期HIV/TB合并感染患者的早期死亡和炎症小体生物标志物升高相关

Ravimohan, Shruthi; Nfanyana, Kebatshabile; Tamuhla, Neo; Tiemessen, Caroline T; Weissman, Drew; Bisson, Gregory P

Elevated Pre-Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection

抗逆转录病毒治疗前CD39+CD8+ T细胞频率升高与晚期人类免疫缺陷病毒/结核病合并感染患者的早期死亡相关

Ravimohan, Shruthi; Tamuhla, Neo; Nfanyana, Kebatshabile; Ni, Houping; Steenhoff, Andrew P; Gross, Robert; Weissman, Drew; Bisson, Gregory P

Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB.

肠道功能障碍的标志物并不能解释 HIV 相关结核病中利福平生物利用度低的原因

Vinnard Christopher, Ravimohan Shruthi, Tamuhla Neo, Pasipanodya Jotam, Srivastava Shashikant, Modongo Chawangwa, Zetola Nicola M, Weissman Drew, Gumbo Tawanda, Bisson Gregory P

Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.

HIV/结核病患者体内全身免疫激活水平较高,导致吡嗪酰胺清除受损

Vinnard Christopher, Ravimohan Shruthi, Tamuhla Neo, Pasipanodya Jotam, Srivastava Shashikant, Modongo Chawangwa, Zetola Nicola M, Weissman Drew, Gumbo Tawanda, Bisson Gregory P